;

Valuation for ProQR Therapeutics NV (id:5489 PRQR)


Financial Strength

NameCurrentVs IndustryVs History
Trailing P/E -7.51
Forward P/E -5.69
Price to sales 15.41
Price to book 8.74
Enterprise to revenue 7.59
Enterprise to ebitda -4.88

CleverShares.com|
2024 ©

1.0.9119.29486